Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment.
about
Hepatitis C Virus and Human Cytomegalovirus-Natural Killer Cell Subsets in Persistent Viral Infections.Dynamic Changes of the Frequency of Classic and Inflammatory Monocytes Subsets and Natural Killer Cells in Chronic Hepatitis C Patients Treated by Direct-Acting Antiviral Agents.Immunological Predictors of Nonresponse to Directly Acting Antiviral Therapy in Patients With Chronic Hepatitis C and Decompensated Cirrhosis.On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis CNatural Killer Cells in Viral Hepatitis.Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during TherapyInterferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo.Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals.The paradox of highly effective sofosbuvir-based combination therapy despite slow viral decline: can we still rely on viral kinetics?Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.Immune regulation in chronic hepatitis C virus infection.NK cells in self-limited HCV infection exhibit a more extensively differentiated, but not memory-like, repertoire.Immune phenotype and function of natural killer and T cells in chronic hepatitis C patients who received a single dose of anti-MicroRNA-122, RG-101.Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy.Rapid reversal of innate immune dysregulation in blood of patients and livers of humanized mice with HCV following DAA therapy.Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis.Rapidly growing hepatocellular carcinoma after direct-acting antiviral treatment of chronic hepatitis C.Things fall apart with hepatocellular carcinoma and direct-acting antivirals.Higher expression of inhibitory CD158b and CD158e NK cell receptor and age predicts treatment response in children with chronic hepatitis C.Human γδ T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug Therapy.Early and late changes in natural killer cells in response to ledipasvir/sofosbuvir treatment.Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents.Rapid changes in peripheral lymphocyte concentrations during interferon-free treatment of chronic hepatitis C virus infection.Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity.Polymorphisms in the hepatitis C virus core and its association with development of hepatocellular carcinomaRecovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir
P2860
Q33694920-816F7227-9B7B-421D-A9AE-C8A86A82786CQ33711206-6F7EF22E-86CB-4E5B-A6A0-22C9397A0E8DQ33745372-522630CA-AEEE-41A1-A325-B48E5733357FQ33803540-0CB9E28B-3FA7-4F4C-A2CC-2CF6814DD3ABQ34505690-FE9840BD-F752-4F3F-9BDE-A1B5276C594FQ36077824-CFA39AC9-6B0A-4096-BF0E-48B00F945D39Q36093940-AB6F0D67-02ED-4842-831B-B1D5B7479962Q36306768-E3CB27FE-B83A-4B71-941C-A8A7BE6E9C65Q38634755-EDB8D4E1-5451-4549-B451-31DA31CA50CCQ38805093-255D81A5-CB98-4F37-9405-7CF08166DFD4Q38902559-A5AFB3F5-44B7-4467-AE13-844EE35E618DQ40240181-C5550BE2-7516-429D-A859-99EE34EDD878Q40291580-B5815380-F438-4114-8F32-BFDF5D1FAA2EQ40703746-A1A26CED-EA4B-407F-9DEA-5E9AE4D62798Q42685448-A77E4144-523B-44CC-B9BF-59262071ECC6Q47569554-0D7BB26E-8ED8-4B72-9D70-58DF145C5AE5Q48106729-30D4E1AA-F1C2-4095-9BCA-301F79E2A600Q48305272-C1FC3A4F-646E-4CC5-8FD6-76CD5697F637Q48337795-B5EBE89D-C125-4051-BEF2-591E759FFD08Q52332749-6DDE918E-D6F0-4994-A9F0-36349D974F21Q52605839-5F536284-5757-4528-B565-8E6FE7B91ED0Q52661693-992D9BD9-660E-449E-BEAB-134D6C140E0EQ52741770-4BE9C0A7-0E0B-4C40-9EBC-1CE40106F10EQ55097758-287224D2-64D1-44EC-B62D-7D68F88C3A2CQ58049177-031B5687-891F-412E-8F7A-D5EB5531AEC3Q58602166-80B78E1F-4AB2-4CD0-80F3-A7CE6A89AC12
P2860
Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Immunological Analysis During ...... tural Killer Cell Compartment.
@en
type
label
Immunological Analysis During ...... tural Killer Cell Compartment.
@en
prefLabel
Immunological Analysis During ...... tural Killer Cell Compartment.
@en
P2093
P2860
P356
P1476
Immunological Analysis During ...... tural Killer Cell Compartment.
@en
P2093
Andre Boonstra
Bettina E Hansen
Gertine van Oord
Harry L A Janssen
Kim Kreefft
Michelle Spaan
Robert J de Knegt
P2860
P304
P356
10.1093/INFDIS/JIV391
P407
P577
2015-07-28T00:00:00Z